About ContraFect Corp
ContraFect Corporation (ContraFect ) is a biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. It intends to address drug-resistant infections using its therapeutic product candidates from its lysin and monoclonal antibody platforms to target conserved regions of either bacteria or viruses (regions that are not prone to mutation). Its product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia, and CF-404, a combination of mAbs for the treatment of life-threatening seasonal and pandemic varieties of influenza. CF-301 and CF-302 are bacteriophage lysins with potent activity against Staph aureus infections.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: CFRXU
- CUSIP:
Key Metrics:
- Previous Close: $0.00
- 50 Day Moving Average: $N/A
- 200 Day Moving Average: $N/A
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -2.74
- P/E Growth: N/A
- Market Cap: $N/A
Additional Links:
Consensus Ratings for ContraFect Corp (NASDAQ:CFRXU) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for ContraFect Corp (NASDAQ:CFRXU)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 10/6/2014 | Roth Capital | Initiated Coverage | Buy | |  |
(Data available from 9/29/2014 forward)
Earnings History for ContraFect Corp (NASDAQ:CFRXU)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for ContraFect Corp (NASDAQ:CFRXU)Current Year EPS Consensus Estimate: $-3.29 EPS
Next Year EPS Consensus Estimate: $-2.00 EPS
Dividend History for ContraFect Corp (NASDAQ:CFRXU)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for ContraFect Corp (NASDAQ:CFRXU)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for ContraFect Corp (NASDAQ:CFRXU)
ContraFect Corp (NASDAQ:CFRXU) Chart for Thursday, September, 29, 2016
